The pharmaceutical industry's reputation among patient groups improved slightly last year, with 57% of over 2,400 surveyed groups rating drugmakers' reputations as "excellent" or "good." This matters to developers and tech professionals because it highlights the growing importance of prioritizing patient needs and safety in pharma innovation. However, concerns persist regarding access and pricing, indicating areas for continued focus and improvement.
Read the full article at STAT News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)



